Drugs / Trivalent influenza vaccine A
Trials 0
Also used as a comparator or background therapy in 2 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT03744104 Comparator | Oct 2018 → Oct 2019 | influenza | Shanghai Institute Of Biological Products | Completed | No outcome recorded |
| Phase 3 | NCT02710409 Comparator | Jan → Jun 2016 | influenza | Jiangsu Province Centers for Disease Control and Prevention | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Trivalent influenza vaccine A | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02710409 ↗ |
| Modality | Vaccine | “Trivalent influenza vaccine A” NCT02710409 ↗ |
| Route | Intramuscular | “0.5 ml/vial, one dose, intramuscular injection on day 0” NCT02710409 ↗ |